Skip to main content
SpringerLink
Log in

Combined Oral Sodium Butyrate and Mesalazine Treatment Compared to Oral Mesalazine Alone in Ulcerative Colitis

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Butyrate represents the main source of energy for colonic epithelial cells; however, its availabilty/utilization is impaired in ulcerative colitis (UC). In the present randomized, double-blind, placebo-controlled pilot study, the safety and efficacy of colonic targeted oral sodium butyrate tablets, coated with a pH-dependent soluble polymer, have been evaluated in ulcerative colitis. Thirty patients with mild to moderate colitis underwent a six-week course of oral sodium butyrate (4 g/day) plus oral mesalazine (2.4 g/day), (Group A) or of oral mesalazine plus placebo (Group B). Clinical, endoscopic, and histologic data were collected at the beginning and the end of the study. Twenty-five patients completed the study (12 in group A, 13 in group B). No untoward side effects were reported. In group A, seven patients underwent remission and four improved; in Group B the numbers were 5 and 5, respectively. After treatment, all clinical parameters had significantly improved in both treatment arms compared to pretreatment findings. The UC disease activity index (UCDAI) score decreased from 7.27 ± 2.02 to 2.58 ± 2.19 (P < 0.05) in the combined treatment group and from 6.07 ± 1.60 to 3.46 ± 1.98 (P < 0.05) in group B. The endoscopic and histologic scores also significantly improved after treatment in both groups (P < 0.05). The difference between the two treatment arms was not significant, but a significantly better improvement vs baseline values (P < 0.05) was observed in the combined treatment group vs the mesalazine group, when considering both the clinical index (Δ9.58 ± 4.19 vs 5.92 ± 3.48) and the UCDAI score (Δ4.67 ± 2.19 vs 2.54 ± 2.18). A more favorable trend, although not significant, was observed for all individual parameters in group A. In conclusion, results of the present pilot study indicate that oral butyrate is safe and well tolerated. These data also suggest that oral butyrate may improve the efficacy of oral mesalazine in active ulcerative colitis and prompt the need of a large scale investigation to confirm the present findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Cummings JH: Short chain fatty acids in the human colon. Gut 22:763-779, 1981

    Google Scholar 

  2. McNeil NI: The contribution of the large intestine to energy supplies in man. Am J Clin Nutr 39:338-342, 1984

    Google Scholar 

  3. Roediger WEW: Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 21:739-748, 1980

    Google Scholar 

  4. Harig JM, Soergel KH, Komorowski RA, Wood CM: Treatment of diversion colitis with short-chain acid irrigation. N Engl J Med 320:23-28, 1989

    Google Scholar 

  5. Nelson R: Intestinal transport co-enzyme A, and colitis in pantothenic acid deficiency. Am J Clin Nutr 21:495-501, 1968

    Google Scholar 

  6. Ellestad-Sayed JJ, Nelson RA, Adson MA, Palmer WM, Soule EH: Pantothenic acid, coenzyme A and human chronic ulcerative and granulomatous colitis. Am J Clin Nutr 29:1333-1338, 1976

    Google Scholar 

  7. Roediger WEW: The colonic epithelium in ulcerative colitis: An energy deficiency disease. Lancet 2:712-715, 1980

    Google Scholar 

  8. Chapman MAS, Grahm MF, Boyle MA, Hutton M, Rogers J, Williams NS: Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut 35:73-76, 1994

    Google Scholar 

  9. Vernia P, Caprilli R, Latella G, Barbetti F, Magliocca FM, Cittadini M: Fecal lactate and ulcerative colitis. Gastroenterology 95:1564-1568, 1988

    Google Scholar 

  10. Breuer RI, Buto SK, Christ ML, et al.: Rectal irrigation with short-chain fatty acids for distal ulcerative colitis. Dig Dis Sci 36:185-187, 1991

    Google Scholar 

  11. Scheppach W, Sommer H, Kirchner T, et al.: Effect of butyrate on the colonic mucosa in distal ulcerative colitis. Gastroenterology 103:51-56, 1992

    Google Scholar 

  12. Scheppach W, German-Austrian SCFA Study Group: Treatment of distal ulcerapve colitis with short-chain fatty acid enemas. A placebo-controlled trial. Dig Dis Sci 41:2254-2259, 1996

    Google Scholar 

  13. Steinhart AH, Hiruki T, Brzezinski A, Baker JP: Treatment of left-sided ulcerative colitis with butyrate enemas: A controlled trial. Aliment Pharmacol Ther. 10:729-736, 1996

    Google Scholar 

  14. Breuer RI, Soergel KH, Lashner BA, et al: Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: A randomized, placebo controlled trial. Gut 40:485-491, 1997

    Google Scholar 

  15. Vernia P, Cittadini M, Caprilli R, Torsoli A: Topical treatment of refractory distal ulcerative colitis with 5-ASA and sodium butyrate. Dig Dis Sci 40:305-307, 1995

    Google Scholar 

  16. Steinhart AH, Brzezinski A, Baker JP: Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas. Am J Gastroenterol 89:179-183, 1994

    Google Scholar 

  17. Vernia P, Marcheggiano A, Caprilli R, et al: SCFA topical treatment in distal ulcerative colitis. Aliment Pharmacol Ther 9:309-313, 1995

    Google Scholar 

  18. Truelove CD, Witts LJ: Cortisone in ulcerative colitis. Br Med J 2:1041-1048, 1995

    Google Scholar 

  19. Ashford M, Fell JT: Targeting drugs to the colon: delivery systems for oral administration. J Drug Targ 2:241-258, 1994

    Google Scholar 

  20. Sutherland LR, Martin F, Greer S, et al: 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 92:1894-1989, 1987

    Google Scholar 

  21. D'Argenio G, Cosenza V, Sorrentini I, et al: Butyrate, mesalamine, and factor XIII in experimental colitis in the rat: Effects on transglutaminase activity. Gastoenterology 106:399-404, 1994

    Google Scholar 

  22. D'Argenio G, Sorrentini I, Cosenza V, et al: Serum and tissue transglutaminase correlates with the severity of inflammation in induced coltis in the rat. Scand J Gastroenterol 27:111-114, 1992

    Google Scholar 

  23. Wilson AJ, Gibson PR: Short chain fatty acids promote colonic epithelial cell migration in vitro. Gastroenterology 110:A1045, 1996

    Google Scholar 

  24. Mortensen FV, Nielsen H, Mulvany MJ, et al: Short chain fatty acids dilate isolated human colonic resistance arteries. Gut 31:1391-1394, 1990

    Google Scholar 

  25. Kvietys PR, Granger DN: Effect of volatile fatty acids on blood flow and oxygen uptake by the dog colon. Gastroenterology 80:962-969, 1981

    Google Scholar 

  26. Rongione AJ, Liu CD, Newton TR, Zinner MJ, Ashley SW, McFadden DW: Short chain fatty acids mediate intestinal absorption. Gastroenterology 110:A835, 1996

    Google Scholar 

  27. Sakata T: Effects of short-chain fatty acids on epithelial cell proliferation and mucus release in the intestine. In Short-Chain Fatty Acids: Metabolism and Clinical Importance. Report of the 10th Ross Conference on Medical Research. AF Roche (ed). Columbus, Ohio, Ross Laboratories, 1991, pp. 63-67

    Google Scholar 

  28. Kripke SA, Fox AD, Berman JM, Settle RG, Rombeau JL: Stimulation of intestinal mucosal growth with intracolonic infusion of SCFA. JPEN 13:109-116, 1989

    Google Scholar 

  29. Gibson PR, Moeller I, Kalegari O, Folino M, Young GP: Contastanting effects of butyrate on differentation of neoplastic and nonneoplastic colonic epithelial cells. J Gastroenterol Hepatol 7:165-172, 1992

    Google Scholar 

  30. Reeder JA, Dickinson JL, Chenevix-Trench G, Antalis TM: Sodium butyrate differentially modulates plasminogen activator inhibitor type-1, urokinase plasminogen activator, and its receptor in a human colon carcinoma cell. Teratogen Carcinogen Mutagen 13:75-88, 1993

    Google Scholar 

  31. Boffa L, Vidali G, Mann R, Allfrey V: Many-fold effects of sodium butyrate on nuclear function. Selective and reversible phosphorylation of histones H1 and H2A and impaired methylation of lysine and arginine residues in nuclear protein fractions. J Biol Chem 256:9612-9621, 1981

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cattedra di Gastroenterologia 1, Universit`a La Sapienza, Roma

    P. Vernia, G. Monteleone, G. Grandinetti, G. Villotti, E. Di Giulio, G. Frieri, A. Marcheggiano, F. Pallone, R. Caprilli & A. Torsoli

  2. Cattedra di Gastroenterologia, Universit`a de L'Aquila, Italy

    P. Vernia, G. Monteleone, G. Grandinetti, G. Villotti, E. Di Giulio, G. Frieri, A. Marcheggiano, F. Pallone, R. Caprilli & A. Torsoli

  3. Cattedra di Gastroenterologia, Universit`a della Magna Graecia, Catanzaro, Italy

    P. Vernia, G. Monteleone, G. Grandinetti, G. Villotti, E. Di Giulio, G. Frieri, A. Marcheggiano, F. Pallone, R. Caprilli & A. Torsoli

Authors
  1. P. Vernia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Monteleone
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Grandinetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Villotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Di Giulio
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Frieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. Marcheggiano
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. F. Pallone
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. R. Caprilli
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. A. Torsoli
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vernia, P., Monteleone, G., Grandinetti, G. et al. Combined Oral Sodium Butyrate and Mesalazine Treatment Compared to Oral Mesalazine Alone in Ulcerative Colitis. Dig Dis Sci 45, 976–981 (2000). https://doi.org/10.1023/A:1005537411244

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005537411244

Search

Navigation